Neo7Bioscience Announces Precision Signal Interception as a Transformative Approach to Pancreatic Cancer Treatment, Surpassing Limitations of Conventional RAS Pathway Suppression

Neo7Bioscience Announces Precision Signal Interception for Pancreatic Cancer Treatment Beyond Conventional RAS Pathway Suppression ...
Labroots

Concurrent Inhibition of The RAS Pathway and Autophagy As a Treatment Approach for Pancreatic Cancer

Pancreatic ductal adenocarcinoma (PDAC) is characterized clinically by poor survival and mechanistically by KRAS- and autophagy-dependent growth. We and others previously demonstrated that inhibition ...

Verastem Updates Strategy for RAS/MAPK Oncology Pipeline

Verastem ( (VSTM)) has shared an announcement. On May 7, 2026, Verastem posted an updated corporate presentation outlining its strategy around AVMAPKI FAKZYNJA co-pack for KRAS mutant recurrent ...

Daraxonrasib explained: The experimental pill giving new hope against pancreatic cancer

New experimental pill, daraxonrasib, nearly doubled survival in metastatic pancreatic cancer patients, offering hope for a ...
News Medical

Study reveals key signaling pathways driving lung cancer metastasis

When it comes to cancer metastasis, it takes two to tango. That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS ...

Molecular Glue Mechanisms that Aim to Prevent Traditional Resistance Pathways

Traditional therapeutics target the inactive conformation of proteins, allowing tumors to adapt and resume signaling.
EurekAlert!

TGF-beta and RAS signaling are both required for lung cancer metastasis, study finds

When it comes to cancer metastasis, it takes two to tango. That was one of the key findings of a new study led by researchers at Memorial Sloan Kettering Cancer Center (MSK): The TGF-beta and RAS ...